Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143525 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143526 |
| CAS No | NA |
| Mol.F. | C14H16N4O3 |
| Mol.Wt. | 288.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143527 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143528 |
| CAS No | NA |
| Mol.F. | C12H15N3O4 |
| Mol.Wt. | 265.27 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143529 |
| CAS No | NA |
| Mol.F. | C7H8ClN3O3 |
| Mol.Wt. | 217.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143530 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143531 |
| CAS No | NA |
| Mol.F. | C15H20N4O3 |
| Mol.Wt. | 304.35 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143532 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143533 |
| CAS No | NA |
| Mol.F. | C15H19ClN4O2 |
| Mol.Wt. | 322.79 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143534 |
| CAS No | NA |
| Mol.F. | C23H29N5O2 |
| Mol.Wt. | 407.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143535 |
| CAS No | NA |
| Mol.F. | C15H17ClN4O2 |
| Mol.Wt. | 320.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143536 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143537 |
| CAS No | NA |
| Mol.F. | C23H27N5O2 |
| Mol.Wt. | 405.50 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143538 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143539 |
| CAS No | NA |
| Mol.F. | C15H18N4O4 |
| Mol.Wt. | 318.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |